Involvement of the insulin-like growth factor binding proteins in the cancer cell response to DNA damage

Journal of Cell Communication and Signaling

Volumn 9, Issue 2, 2015, Pages 167-176

  Chua, Melissa W Y ^a   Lin, Mike Z ^a   Martin, Janet L ^a   Baxter, Robert C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cancer; Chemotherapy; IGFBP; Non homologous end joining; p53; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE; DNA; DNA DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 6; SPHINGOSINE 1 PHOSPHATE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CELL AGING; CELL CYCLE; CELL FATE; CELL REGENERATION; CHEMOSENSITIVITY; CLINICAL TRIAL (TOPIC); DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DNA RESPONSIVE ELEMENT; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVE SITE; GENE MUTATION; GENOTOXICITY; HOMOLOGOUS RECOMBINATION; HUMAN; INTRON; LIPOGENESIS; LUNG CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN INTERACTION; RADIOSENSITIVITY;

EID: 84930537871     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-015-0262-1     Document Type: Article

References (96)

1. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177–2196
2. Abraham RT (2004) PI 3-kinase related kinases: ‘Big’ players in stress-induced signaling pathways. DNA Repair 3:883–887
3. Achary MP, Jaggernauth W, Gross E, Alfieri A, Klinger HP, Vikram B (2000) Cell lines from the same cervical carcinoma but with different radiosensitivities exhibit different cDNA microarray patterns of gene expression. Cytogenet Cell Genet 91:39–43
4. Aureli M, Murdica V, Loberto N, Samarani M, Prinetti A, Bassi R, Sonnino S (2014) Exploring the link between ceramide and ionizing radiation. Glycoconj J 31:449–459
5. Barbieri CE, Perez CA, Johnson KN, Ely KA, Billheimer D, Pietenpol JA (2005) IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res 65:2314–2320
6. Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–E976
7. Baxter RC (2014) IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14:329–341
8. Beattie J, McIntosh L, van der Walle CF (2010) Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol 224:605–611
9. Bernstein NK, Hammel M, Mani RS, Weinfeld M, Pelikan M, Tainer JA, Glover JNM (2009) Mechanism of DNA substrate recognition by the mammalian DNA repair enzyme, Polynucleotide Kinase. Nucleic Acids Res 37:6161–6173
10. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG, Maurer M, Gilchrest BA, Gudkov AV (2000) p53 is essential for chemotherapy-induced hair loss. Cancer Res 60:5002–5006
11. Bozulic L, Surucu B, Hynx D, Hemmings BA (2008) PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival. Mol Cell 30:203–213
12. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646–649
13. Butt AJ, Firth SM, King MA, Baxter RC (2000) Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 275:39174–39181
14. Butt AJ, Dickson KA, McDougall F, Baxter RC (2003) Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278:29676–29685
15. Chen DJ, Nirodi CS (2007) The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage. Clin Cancer Res 13:6555–6560
16. Chen BP, Chan DW, Kobayashi J, Burma S, Asaithamby A, Morotomi-Yano K, Botvinick E, Qin J, Chen DJ (2005) Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J Biol Chem 280:14709–14715
17. Chen BP, Uematsu N, Kobayashi J, Lerenthal Y, Krempler A, Yajima H, Lobrich M, Shiloh Y, Chen DJ (2007) Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem 282:6582–6587
18. Chuang ST, Patton KT, Schafernak KT, Papavero V, Lin F, Baxter RC, Teh BT, Yang XJ (2008) Over expression of insulin-like growth factor binding protein 3 in clear cell renal cell carcinoma. J Urol 179:445–449
19. Cobb LJ, Liu B, Lee KW, Cohen P (2006) Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. Cancer Res 66:10878–10884
20. Cobb LJ, Mehta H, Cohen P (2009) Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation. Mol Endocrinol 23:1624–1633
21. Cottarel J, Frit P, Bombarde O, Salles B, Négrel A, Bernard S, Jeggo PA, Lieber MR, Modesti M, Calsou P (2013) A noncatalytic function of the ligation complex during nonhomologous end joining. J Cell Biol 200:173–186
22. d’Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8:512–522
23. Davis AJ, Chen BP, Chen DJ (2014) DNA-PK: a dynamic enzyme in a versatile DSB repair pathway. DNA Repair (Amst) 17:21–29
24. Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP (2005) Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase. J Biol Chem 280:31182–31189
25. Dittmann K, Mayer C, Kehlbach R, Rodemann HP (2008) Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol Cancer 7:69. doi:10.1186/1476-4598-1187-1169
26. Dobbs TA, Tainer JA, Lees-Miller SP (2010) A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation. DNA Repair (Amst) 9:1307–1314
27. Drivdahl RH, Sprenger C, Trimm K, Plymate SR (2001) Inhibition of Growth and Increased Expression of Insulin-Like Growth Factor-Binding Protein-3 (IGFBP-3) and -6 in Prostate Cancer Cells Stably Transfected with Antisense IGFBP-4 Complementary Deoxyribonucleic Acid. Endocrinology 142:1990–1998
28. Falck J, Coates J, Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434:605–611
29. Forbes BE, McCarthy P, Norton RS (2012) Insulin-like growth factor binding proteins: a structural perspective. Front Endocrinol (Lausanne) 3:38
30. Fowler CA, Perks CM, Newcomb PV, Savage PB, Farndon JR, Holly JMP (2000) Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. Int J Cancer 88:448–453
31. Gill ZP, Perks CM, Newcomb PV, Holly JMP (1997) Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner. J Biol Chem 272:25602–25607
32. Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF, Valerie K (2007) Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 67:1046–1053
33. Golding SE, Morgan RN, Adams BR, Hawkins AJ, Povirk LF, Valerie K (2009) Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther 8:730–738
34. Granata R, De Petrini M, Trovato L, Ponti R, Pons N, Ghe C, Graziani A, Ferry RJ Jr, Muccioli G, Ghigo E (2003) Insulin-like growth factor binding protein-3 mediates serum starvation- and doxorubicin-induced apoptosis in H9c2 cardiac cells. J Endocrinol Invest 26:1231–1241
35. Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, Sala G, Ghidoni R, Ghigo E (2004) Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. FASEB J 18:1456–1458
36. Grimberg A, Coleman CM, Burns TF, Himelstein BP, Koch CJ, Cohen P, El-Deiry WS (2005) p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. J Clin Endocrinol Metab 90:3568–3574
37. Grimberg A, Coleman CM, Shi Z, Burns TF, MacLachlan TK, Wang W, El-Deiry WS (2006) Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signaling. Cancer Biol Ther 5:1408–1414
38. Grundy GJ, Moulding HA, Caldecott KW, Rulten SL (2014) One ring to bring them all–the role of Ku in mammalian non-homologous end joining. DNA Repair (Amst) 17:30–38
39. Han S, Li Z, Master LM, Master ZW, Wu A (2014) Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin beta1-ERK pathway. Br J Cancer 111:1400–1409
40. Hanafusa T, Shinji T, Shiraha H, Nouso K, Iwasaki Y, Yumoto E, Ono T, Koide N (2005) Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation. BMC Cancer 5:9
41. Harms KL, Chen X (2005) The C terminus of p53 family proteins is a cell fate determinant. Mol Cell Biol 25:2014–2030
42. Hollowood AD, Lai T, Perks CM, Newcomb PV, Alderson D, Holly JMP (2000) IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer 88:336–341
43. Huertas P (2010) DNA resection in eukaryotes: deciding how to fix the break. Nat Struct Mol Biol 17:11–16
44. Iosef C, Vilk G, Gkourasas T, Lee KJ, Chen BP, Fu P, Bach LA, Lajoie G, Gupta MB, Li SS et al (2010) Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate. Cell Signal 22:1033–1043
45. Jackson SP, Bartek J (2009) The DNA-damage response in human biology and human disease. Nature 461:1071–1078
46. Javvadi P, Makino H, Das AK, Lin YF, Chen DJ, Chen BP, Nirodi CS (2012) Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance. Mol Cancer Res 10:1359–1368
47. Kakarougkas A, Jeggo PA (2014) DNA DSB repair pathway choice: an orchestrated handover mechanism. Br J Radiol 87:20130685
48. Khan E, Heidinger J, Levy M, Lisanti M, Ravid T, Goldkorn T (2006) Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking. J Biol Chem 281:14486–14493
49. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR (2007) Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18:4543–4552
50. Kriegs M, Kasten-Pisula U, Rieckmann T, Holst K, Saker J, Dahm-Daphi J, Dikomey E (2010) The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining. DNA Repair (Amst) 9:889–897
51. Krietsch J, Caron MC, Gagne JP, Ethier C, Vignard J, Vincent M, Rouleau M, Hendzel MJ, Poirier GG, Masson JY (2012) PARP activation regulates the RNA-binding protein NONO in the DNA damage response to DNA double-strand breaks. Nucleic Acids Res 40:10287–10301
52. Leu JI, George DL (2007) Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev 21:3095–3109
53. Lieber MR (2010) The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway. Annu Rev Biochem 79:181–211
54. Lin MZ, Marzec KA, Martin JL, Baxter RC (2014) The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Oncogene 33:85–96
55. Loughery J, Cox M, Smith LM, Meek DW (2014) Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters. Nucleic Acids Res 42:7666–7680
56. Martin JL, Lin MZ, McGowan EM, Baxter RC (2009) Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J Biol Chem 284:25542–25552
57. Martin JL, de Silva HC, Lin MZ, Scott CD, Baxter RC (2014) Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade. Mol Cancer Ther 13:316–328
58. Meek K, Gupta S, Ramsden DA, Lees-Miller SP (2004) The DNA-dependent protein kinase: the director at the end. Immunol Rev 200:132–141
59. Moynahan ME, Jasin M (2010) Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 11:196–207
60. Nick McElhinny SA, Snowden CM, McCarville J, Ramsden DA (2000) Ku Recruits the XRCC4-Ligase IV Complex to DNA Ends. Mol Cell Biol 20:2996–3003
61. Olsen BB, Issinger OG, Guerra B (2010) Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells. Oncogene 29:6016–6026
62. Pawelczak KS, Bennett SM, Turchi JJ (2011) Coordination of DNA-PK activation and nuclease processing of DNA termini in NHEJ. Antioxid Redox Signal 14:2531–2543
63. Pchejetski D, Doumerc N, Golzio M, Naymark M, Teissie J, Kohama T, Waxman J, Malavaud B, Cuvillier O (2008) Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther 7:1836–1845
64. Perks CM, Bowen S, Gill ZP, Newcomb PV, Holly JM (1999) Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J Cell Biochem 75:652–664
65. Perks CM, McCaig C, Clarke JB, Clemmons DR, Holly JM (2002) A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. Biochem Biophys Res Commun 294:988–994
66. Pintens S, Neven P, Drijkoningen M, Van Belle V, Moerman P, Christiaens M-R, Smeets A, Wildiers H, Bempt IV (2009) Triple negative breast cancer: a study from the point of view of basal CK5/6 and HER-1. J Clin Pathol 62:624–628
67. Reynolds R, Witherspoon S, Fox T (2004) The infant mouse as a in vivo model for the detection and study of DNA damage-induced changes in the liver. Mol Carcinog 40:62–72
68. Riballo E, Kühne M, Rief N, Doherty A, Smith GCM, Recio M-J, Reis C, Dahm K, Fricke A, Krempler A et al (2004) A Pathway of Double-Strand Break Rejoining Dependent upon ATM, Artemis, and Proteins Locating to γ-H2AX Foci. Mol Cell 16:715–724
69. Salton M, Lerenthal Y, Wang SY, Chen DJ, Shiloh Y (2010) Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle 9:1568–1576
70. San Filippo J, Sung P, Klein H (2008) Mechanism of Eukaryotic Homologous Recombination. Annu Rev Biochem 77:229–257
71. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189–199
72. Sbisa E, Catalano D, Grillo G, Licciulli F, Turi A, Liuni S, Pesole G, De Grassi A, Caratozzolo MF, D’Erchia AM et al (2007) p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data. BMC Bioinforma 8(Suppl 1):S20
73. Schedlich LJ, Nilsen T, John AP, Jans DA, Baxter RC (2003) Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 144:1984–1993
74. Shao ZM, Sheikh MS, Ordonez JV, Feng P, Kute T, Chen JC, Aisner S, Schnaper L, LeRoith D, Roberts CT Jr et al (1992) IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res 52:5100–5103
75. Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher‐Scholz G, Löbrich M et al (2011) Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J 30:1079–1092
76. Shikazono N, Noguchi M, Fujii K, Urushibara A, Yokoya A (2009) The Yield, Processing, and Biological Consequences of Clustered DNA Damage Induced by Ionizing Radiation. J Radiat Res 50:27–36
77. Sirbu BM, Cortez D (2013) DNA damage response: three levels of DNA repair regulation. Cold Spring Harb Perspect Biol 5:a012724
78. Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA (2006) Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci U S A 103:13028–13033
79. Smith J, Tho LM, Xu N, Gillespie DA (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108:73–112
80. Sperka T, Wang J, Rudolph KL (2012) DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol 13:579–590
81. Thompson LH (2012) Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat Res 751:158–246
82. Toulany M, Kehlbach R, Florczak U, Sak A, Wang S, Chen J, Lobrich M, Rodemann HP (2008) Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther 7:1772–1781
83. Truman JP, Garcia-Barros M, Obeid LM, Hannun YA (2014) Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim Biophys Acta 1841:1174–1188
84. Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, Taucher-Scholz G, Mari PO, Van Gent DC, Chen BP, Chen DJ (2007) Autophosphorylation of DNA-PKCS regulates its dynamics at DNA double-strand breaks. J Cell Biol 177:219–229
85. Viale G, Rotmensz N, Maisonneuve P, Bottiglieri L, Montagna E, Luini A, Veronesi P, Intra M, Torrisi R, Cardillo A et al (2009) Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity. Breast Cancer Res Treat 116:317–328
86. Vikhanskaya F, Lee MK, Mazzoletti M, Broggini M, Sabapathy K (2007) Cancer-derived p53 mutants suppress p53-target gene expression–potential mechanism for gain of function of mutant p53. Nucleic Acids Res 35:2093–2104
87. Weterings E, Chen DJ (2008) The endless tale of non-homologous end-joining. Cell Res 18:114–124
88. Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C (2000) Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res 60:22–27
89. Woods D, Turchi JJ (2013) Chemotherapy induced DNA damage response: convergence of drugs and pathways. Cancer Biol Ther 14:379–389
90. Xiao CY, Hubner S, Jans DA (1997) SV40 large tumor antigen nuclear import is regulated by the double-stranded DNA-dependent protein kinase site (serine 120) flanking the nuclear localization sequence. J Biol Chem 272:22191–22198
91. Xie L, Tsaprailis G, Chen QM (2005) Proteomic identification of insulin-like growth factor-binding protein-6 induced by sublethal H2O2 stress from human diploid fibroblasts. Mol Cell Proteomics 4:1273–1283
92. Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC (2008) Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Pancreas 36:160–167
93. Yamada PM, Lee KW (2009) Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 296:C954–C976
94. Yoshino K, Motoyama S, Koyota S, Shibuya K, Usami S, Maruyama K, Saito H, Minamiya Y, Sugiyama T, Ogawa J (2011) IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells. Biochem Biophys Res Commun 404:1070–1075
95. Zhao L, Li QQ, Zhang R, Xi M, Liao YJ, Qian D, He LR, Zeng YX, Xie D, Liu MZ (2012) The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin. Tumour Biol 33:1115–1123
96. Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408:433–439